Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice
In Vivo · 2024
DOI: 10.21873/invivo.13734 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Renee Fisher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A. Hauptthemen laut MEDLINE: Fanconi Anemia, Fanconi Anemia Complementation Group D2 Protein, Fanconi Anemia Complementation Group G Protein, Methylcholanthrene. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND/AIM: Radiation oncologists are reluctant to treat cancer in Fanconi Anemia (FA) patients due to their lack of homologous recombination repair of DNA strand breaks in normal tissues. To determine the therapeutic effects of irradiation and combination chemotherapy on cancer in syngeneic, radiosensitive FA mice, we derived transplantable cancers of the same genotype in three FA mouse strains. MATERIALS AND METHODS: Fancd2-/- mice on a C57BL/6 or Sv/129 background and Fancg-/- mice (C57BL/6 background) that received 3-methylcholanthrene (3-MCA), were monitored for the development of subcutaneous tumors. RESULTS: Tumors were induced at the site of 3-MCA injection, and tumor cell lines were established and found to be transplantable. Explanted tumors were identified as pleomorphic/rhabdomyosarcomas using immunohistochemical biomarkers. CONCLUSION: These transplantable FA mouse tumor cell lines should be valuable for testing effects of new radiation therapy protocols including FLASH high dose rate radiation delivery, immunotherapies, and combined radiation and chemotherapy treatments for radiosensitive FA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
- Department of DLAR-Veterinary Services, University of Pittsburgh, Pittsburgh, PA, U.S.A.
- Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A. greenbergerjs@upmc.edu.
- Department of Pathology, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Förderung
- NCI NIH HHS
Zitieren
APA
Fisher, R., Epperly, M. W., Rigatti, L. H., Shields, D., Greenberger, J. S., Green, A., & Mukherjee, A. (2024). Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice. In Vivo. https://doi.org/10.21873/invivo.13734
Vancouver
Fisher R, Epperly MW, Rigatti LH, Shields D, Greenberger JS, Green A, et al. Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice. In Vivo. 2024. doi:10.21873/invivo.13734
BibTeX
@article{Fisher2024,
author = {Fisher, Renee and Epperly, Michael W and Rigatti, Lora H and Shields, Donna and Greenberger, Joel S and Green, Anthony and Mukherjee, Amitava},
title = {Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13734}
}
EUVIMED